MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Eye movement"

  • 2024 International Congress

    Free-Viewing Eye Tracking and the Effect of Levodopa in Parkinson’s Disease

    A. Gallagher, H. Elliott, J. Inocentes, C. O'Keeffe, B. Coe, D. Brien, B. White, H. Riek, R. Walsh, T. Lynch, R. Reilly, D. Munoz, C. Fearon (Dublin 7, Ireland)

    Objective: The objective of our study is to determine whether differences in oculomotor function and blink rate correlate to the off-and on- medication state in a cohort of…
  • 2024 International Congress

    Bedside Assessment of Downgaze Palsy by Amplitude in Patients with Progressive Supranuclear Palsy

    T. Xie, M. Padmanaban, W. Abou Chaar, J. Nichols (Chicago, USA)

    Objective: To assess the specificity and reliability of the bedside assessment of downgaze palsy by amplitude based on the upper edge of the iris relative to…
  • 2024 International Congress

    Eye movements and cognitive function

    A. Ovchynnykova, Y. Trufanov, M. Trishchynska (Kyiv, Ukraine)

    Objective: find out the relationship between eye movements and cognitive function (CF). Background: working in our clinic we have learned to give a pre-assessment of…
  • 2024 International Congress

    Evaluating Cognitive Status in Parkinson’s Disease Using a Software-based Eye-Tracking Platform: Preliminary Results of the PALOMA Clinical Trial

    M. Tosin, C. Goetz, R. Armstrong, C. Januario, B. Balint, P. Mir (Chicago, USA)

    Objective: To investigate the correlation between the cognitive status of Parkinson's disease (PD) patients and oculomotor parameters captured by a software-based eye-tracking platform using artificial…
  • 2024 International Congress

    Evidence of basal ganglia involvement in mask-induced inhibition

    P. Daye, A. Sangaré, B. Gaymard, P. Pouget (Ottignies-Louvain-la-Neuve, Belgium)

    Objective: This study evaluates if basal ganglia inhibitory projections to the superior colliculus are involved in the saccadic mask inhibition phenomenon. Background: Saccadic mask inhibition is…
  • 2024 International Congress

    Looking Away: Anxiety Interferes with the Ability of Freezers to Attend to Visual Cues

    P. Norouzian, A. Zafar, S. Lewis, K. Ehgoetz Martens (Waterloo, Canada)

    Objective: To evaluate the influence of anxiety on attentional allocation when visual cues are provided for Parkinson’s Disease patients with freezing of gait. Background: It…
  • 2024 International Congress

    Performance of a Smartphone-based Oculomotor Test as a Diagnostic Tool for Parkinson’s Disease

    C. Edwards, A. Zirra, IA. John, A. Bogucki, R. Torricelli, J. Kenny, S. Ganesh, K. Dey, T. Haque, D. Gallagher, C. Budu, C. Simonet, M. Wlodarski, J. Neffendorf, R. Chrapkiewicz, SG. Manohar, AJ. Noyce (London, United Kingdom)

    Objective: First, to ascertain whether a smartphone-based application measuring saccadic parameters can differentiate between patients with Parkinson’s disease (PD) and healthy controls (HC). Second, to…
  • 2024 International Congress

    Hierarchical Machine Learning Classification of Parkinsonian Disorders using Saccades

    O. Bredemeyer, S. Patel, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: To evaluate the discriminative power of a novel saccade waveform reconstruction approach compared to conventional saccadic metrics in differentiating Parkinson's disease (PD), progressive supranuclear…
  • 2024 International Congress

    4-Aminopyridine improves downbeat nystagmus in SCA27b: A case report

    S. Coulette, M. Philibert, JM. Trocello, B. Gaymard, C. Desjardins (Paris, France)

    Objective: To assess objective clinical improvement in video-oculography in a patient with SCA27b on 4-aminopyridine (4-AP) treatment. Background: Spinocerebellar ataxia 27b (SCA27b; MIM 620174) is…
  • 2024 International Congress

    Opsoclonus after Covid-19 infection

    F. Sakeff, A. Vilar (São Paulo, Brazil)

    Objective: Describe the first Brazilian case of opsoclonus due to COVID-19 infection Background: Opsoclonus-myoclonus is a rare movement disorder associated with a variety of conditions,…
  • 1
  • 2
  • 3
  • …
  • 12
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley